Ethical Aspects of Using CRISPR-Cas9 in Medicine in Kazakhstan and Worldwide

Journal of Clinical Medicine of Kazakhstan, 2026

Полный текст Открытый доступ: Gold Метаданные (CSL-JSON)
DOI 10.23950/jcmk/17746
Достоверность данных 70 средняя
Как считается эта оценка

Складывается из проверяемых признаков самой записи: есть ли у статьи DOI, сколько независимых источников подтвердили её данные, заполнены ли обязательные поля и насколько свежо последнее подтверждение. Снижают оценку расхождения между источниками и отсутствие идентификатора. Значение от 80 означает, что запись опубликована без дополнительной проверки; от 60 до 79 — что она опубликована с пониженной достоверностью и ручная проверка желательна. Запись, выверенную редактором вручную, пересчёт не опускает ниже 90. Это оценка наших данных о статье, а не оценка самой статьи.

Аннотация

CRISPR-Cas9 is a new emerging genome editing tool, that gives hope as a cure to various diseases, including cancer and hereditary diseases. Although its accuracy in editing DNA is fascinating, recent breakthroughs in this field raise crucial ethical and legal issues. Usage of CRISPR-Cas9 raises concerns pertaining to safety, availability, religious and societal impact. Nowadays, some of the high-income countries have developed regulatory frameworks to address these concerns, however there is still a lack of global concrete regulations for all nations. In Kazakhstan, even though genome editing technology is used mostly in research, we are in demand of developing bioethical principles based on international practices. The regulatory framework would ensure a responsible approach in using this tool in medicine and research. In this review, we explored international ethical practices and examined the current situation in Kazakhstan in implementing genome editing technology. CRISPR-Cas9 is a new emerging genome editing tool, that gives hope as a cure to various diseases, including cancer and hereditary diseases. Although its accuracy in editing DNA is fascinating, recent breakthroughs in this field raise crucial ethical and legal issues. Usage of CRISPR-Cas9 raises concerns pertaining to safety, availability, religious and societal impact. Nowadays, some of the high-income countries have developed regulatory frameworks to address these concerns, however there is still a lack of global concrete regulations for all nations. In Kazakhstan, even though genome editing technology is used mostly in research, we are in demand of developing bioethical principles based on international practices. The regulatory framework would ensure a responsible approach in using this tool in medicine and research. In this review, we explored international ethical practices and examined the current situation in Kazakhstan in implementing genome editing technology.